This filing is purely administrative with no trading implications. Monitor for clinical trial catalysts or financing events that could move the stock; the option lapses and grants are immaterial to near-term valuation.
Price Chart
Executive Summary
Radiopharm Theranostics filed a 6-K reporting routine ASX notifications: the lapse of 37.2 million unquoted options (RADAN and RADAJ) due to unmet conditions, and the issuance of 2.7 million new options under an employee incentive scheme. These are administrative capital structure adjustments with no material financial or operational impact.
Key Facts
- 37,224,710 options (RADAN and RADAJ) lapsed between Nov 2025 and May 2026 due to conditions not being satisfied
- 2,666,666 new RADAN options issued on June 30, 2026 under an employee incentive scheme, not intended for ASX quotation
- Total ordinary shares outstanding remain at 3,544,216,160; total quoted options exceed 2 billion across multiple series
- Filing contains no financial results, guidance, or business updates
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-073447 |
| Document: ea029645901ex99-1.htm | 0001213900-26-073447 |
| Document: ea0296459-6k_radiopharm.htm | 0001213900-26-073447 |
| Document: 0001213900-26-073447-index-headers.html | 0001213900-26-073447 |
| Document: 0001213900-26-073447-index.html | 0001213900-26-073447 |
| Document: 0001213900-26-073447.txt | 0001213900-26-073447 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+5 | — | — |
Oct 20, 2026 6d ago | 6-K | $0.9900 | awaiting T+5 | — | $0.9600 (−3.03%) |
Oct 14, 2026 11d ago | SC 13G | $1.08 $0.9500 | ▼ −12.04% | ▼ −11.02% | $0.9600 (−11.11%) |
Oct 5, 2026 21d ago | 6-K | $1.27 $1.11 | ▼ −12.60% | ▼ −13.02% | $0.9600 (−24.41%) |
Oct 1, 2026 25d ago | 6-K | $1.48 $1.11 | ▼ −25.00% | ▼ −26.30% | $0.9600 (−35.14%) |
Sep 30, 2026 26d ago | 6-K | $1.62 $1.15 | ▼ −29.01% | ▼ −30.93% | $0.9600 (−40.74%) |
Sep 24, 2026 4w ago | EFFECT | $1.57 $1.48 | ▲ +5.85% | ▲ +5.43% | $0.9600 (+38.93%) |
Sep 22, 2026 4w ago | 6-K | $1.65 $1.52 | ▼ −7.88% | ▼ −6.69% | $0.9600 (−41.82%) |
Sep 14, 2026 6w ago | 6-K | $2.01 $1.61 | ▼ −19.90% | ▼ −20.01% | $0.9600 (−52.24%) |
Sep 11, 2026 6w ago | 6-K | $1.98 $1.65 | ▼ −16.67% | ▼ −16.45% | $0.9600 (−51.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers